Mahmoudpour, SH;
Asselbergs, FW;
Souverein, PC;
de Boer, A;
Maitland-van der Zee, AH;
(2018)
Prescription patterns of angiotensin-converting enzyme inhibitors for various indications: A UK population-based study.
British Journal of Clinical Pharmacology
, 84
(10)
pp. 2365-2372.
10.1111/bcp.13692.
Preview |
Text
Asselbergs_20180522_descriptive CPRD_final_revised_highlighted.merged.pdf - Accepted Version Download (214kB) | Preview |
Abstract
AIM: Angiotensin‐converting enzyme inhibitors (ACEIs) are widely prescribed for several cardiovascular indications. This study investigated patterns of ACEI use for various indications. METHODS: A descriptive, retrospective population‐based study was conducted using data from the UK Clinical Practice Research Datalink. Patients starting ACEIs (2007–2014) were selected and ACEI indications were retrieved from electronically recorded medical records. Stratified by indication, we distinguished between persistent and nonpersistent ACEI use, considering a 6‐month interval between two prescription periods as a maximum for persistent use. Five‐year persistence rates for various indications were calculated using the Kaplan–Meier method and compared in a log‐rank test. Nonpersistent users were subdivided into three groups: (i) stop; (ii) restart; and (iii) switch to an angiotensin II‐receptor blocker. Patients who received ACEIs for hypertension who switched to other classes of antihypertensive medications were further investigated. RESULTS: In total, 254 002 ACEI initiators were identified with hypertension (57.6%), myocardial infarction (MI; 4.2%), renal disease (RD; 3.7%), heart failure (HF; 1.5%), combinations of the above (17.2%) or none of the above (15.8%). Five‐year persistence rates ranged from 43.2% (RD) to 68.2% (MI; P < 0.0001). RD and HF patients used ACEIs for the shortest time (average 23.6 and 25.0 months, respectively). For the nonpersistent group, the percentage of switchers to angiotensin II‐receptor blockers ranged from 27.6% (RD) to 42.2% (MI) and the restarters ranged from 15.0% (HF) to 18.1% (group without indication). CONCLUSIONS: Depending on the indication, there are various rates of ACEI nonpersistence. Patients with RD are most likely to discontinue treatment.
| Type: | Article |
|---|---|
| Title: | Prescription patterns of angiotensin-converting enzyme inhibitors for various indications: A UK population-based study |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1111/bcp.13692 |
| Publisher version: | https://doi.org/10.1111/bcp.13692 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | ACE inhibitors, heart failure, hypertension, medication persistence, myocardial infarction, renal disease |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Health Informatics |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10057852 |
Archive Staff Only
 |
View Item |
